
(UPDATED on 7/20/16 at 1:40 p.m. ET to clarify GHRP-6 itself isn’t a growth hormone and instead encourages the body to increase growth hormone production.)
USADA officials today announced three-time UFC featherweight title challenger Chad Mendes has been given a two-year suspension after failing a drug test related to a growth hormone.
Mendes (17-4 MMA, 8-4 UFC) was tested out-of-competition via a urine sample on May 17 and came back positive for GHRP-6, or growth hormone-releasing Hexapeptide, according to the website for the UFC’s anti-doping partner.
GHRP-6 is classified under the substance category of peptide hormones, growth factors, related substances and mimetics, and it is banned year-round by WADA, to which USADA is a signatory.
Per USADA, the standard sanction for an anti-doping policy violation involving a non-specified substance is a two-year period of ineligibility. Mendes also has been “disqualified from all competitive results obtained on and subsequent to May 17, 2016, the date of sample collection, including forfeiture of any title, ranking, purse or other compensation.”
UFC's Chad Mendes receives 2-year USADA suspension (Updated)
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
No shocker here after his response to the news, but Chad Mendes has been given a 2-year suspension after testing positive for HGH. This is per Jeremy Botter.
EDIT: Actually looks like mmafighting.com got it first.
SECOND EDIT: Apparently it was for growth hormone peptides, which is different than just HGH. Botter strikes again.
Last edited by a moderator: